Braun Bostich & Associates Inc. Purchases 102 Shares of The Procter & Gamble Company (NYSE:PG)

Braun Bostich & Associates Inc. boosted its position in shares of The Procter & Gamble Company (NYSE:PG) by 3.1% during the 4th quarter, HoldingsChannel.com reports. The fund owned 3,379 shares of the company’s stock after buying an additional 102 shares during the quarter. Braun Bostich & Associates Inc.’s holdings in Procter & Gamble were worth $566,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. RPg Family Wealth Advisory LLC acquired a new stake in Procter & Gamble in the 3rd quarter valued at about $33,000. Costello Asset Management INC boosted its stake in shares of Procter & Gamble by 2,142.9% during the 3rd quarter. Costello Asset Management INC now owns 314 shares of the company’s stock worth $54,000 after acquiring an additional 300 shares during the period. William B. Walkup & Associates Inc. acquired a new position in shares of Procter & Gamble during the 2nd quarter worth approximately $58,000. Mendota Financial Group LLC raised its stake in Procter & Gamble by 58.0% in the 4th quarter. Mendota Financial Group LLC now owns 376 shares of the company’s stock valued at $63,000 after acquiring an additional 138 shares during the period. Finally, Itau Unibanco Holding S.A. lifted its holdings in Procter & Gamble by 138.7% during the 3rd quarter. Itau Unibanco Holding S.A. now owns 401 shares of the company’s stock valued at $69,000 after purchasing an additional 233 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Up 0.9 %

NYSE PG opened at $166.20 on Friday. The Procter & Gamble Company has a fifty-two week low of $152.06 and a fifty-two week high of $180.43. The business has a fifty day moving average price of $168.97 and a two-hundred day moving average price of $169.38. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The stock has a market capitalization of $391.41 billion, a PE ratio of 28.66, a PEG ratio of 3.64 and a beta of 0.45.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Wednesday, January 22nd. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.86 by $0.02. The business had revenue of $21.88 billion for the quarter, compared to analyst estimates of $21,657,595.49 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. Procter & Gamble’s revenue was up 2.1% compared to the same quarter last year. During the same period last year, the firm posted $1.84 earnings per share. Equities analysts expect that The Procter & Gamble Company will post 6.92 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Friday, January 24th will be given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.42%. The ex-dividend date is Friday, January 24th. Procter & Gamble’s dividend payout ratio is 69.48%.

Insider Activity at Procter & Gamble

In related news, CEO Gary A. Coombe sold 47,847 shares of the firm’s stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the sale, the chief executive officer now owns 39,977 shares of the company’s stock, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $172.73, for a total value of $2,210,944.00. Following the completion of the transaction, the insider now directly owns 11,595 shares of the company’s stock, valued at approximately $2,002,804.35. The trade was a 52.47 % decrease in their position. The disclosure for this sale can be found here. 0.18% of the stock is owned by insiders.

Analysts Set New Price Targets

PG has been the topic of several research analyst reports. Evercore ISI increased their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research report on Monday, October 21st. JPMorgan Chase & Co. cut their price objective on shares of Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating for the company in a research report on Thursday, January 16th. UBS Group decreased their target price on Procter & Gamble from $196.00 to $189.00 and set a “buy” rating on the stock in a research report on Thursday, January 16th. DA Davidson reissued a “buy” rating and set a $209.00 price target on shares of Procter & Gamble in a report on Thursday. Finally, Morgan Stanley upped their price objective on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a report on Monday, October 21st. Eight equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $180.25.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.